和铂医药-B(02142.HK)11月7日耗资497万港元回购40万股
Core Viewpoint - Heptagon Pharmaceuticals-B (02142.HK) announced a share buyback of 400,000 shares at a cost of HKD 4.97 million on November 7 [1] Group 1 - The company executed a buyback program, indicating confidence in its stock value [1] - The total expenditure for the buyback was HKD 4.97 million [1] - The number of shares repurchased was 400,000 [1]